Benzinga | Oct 6, 2021 09:51AM EDT

Fate Therapeutics Sponsored Study Titled 'FT538 in Combination With Monoclonal Antibodies in Advanced Solid Tumors' Posted To ClinicalTrials.Gov; Study Not Yet Recruiting

https://clinicaltrials.gov/ct2/show/NCT05069935